| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $114.1M | +33.9% |
| SG&A Expense | $28.8M | +12.6% |
| Operating Income | -$142.9M | -29.0% |
| Income Tax | $0 | — |
| Net Income | -$127.8M | -27.0% |
| EPS (Basic) | -$1.83 | +6.6% |
| EPS (Diluted) | -$1.83 | +6.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $59.4M | +154.0% |
| Current Assets | $262.3M | +23.4% |
| Total Assets | $274.1M | +8.8% |
| Current Liabilities | $24.8M | +21.4% |
| Total Liabilities | $31.0M | +11.1% |
| Stockholders' Equity | $243.1M | +8.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$112.7M | -31.5% |
| Capital Expenditures | $1.2M | +39.9% |
| Investing Cash Flow | $22.1M | +151.0% |
| Financing Cash Flow | $126.5M | +47.7% |
| Free Cash Flow | -$113.8M | -31.6% |